Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19776408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline Mesylate;   Other: Placebo

Indicates status has not been verified in more than two years